MX9202804A - PHARMACEUTICAL AND THERAPEUTIC COMPOSITION THAT INCLUDES A NEW MOLECULA OF INTRACELLULAR ADHESION. - Google Patents
PHARMACEUTICAL AND THERAPEUTIC COMPOSITION THAT INCLUDES A NEW MOLECULA OF INTRACELLULAR ADHESION.Info
- Publication number
- MX9202804A MX9202804A MX9202804A MX9202804A MX9202804A MX 9202804 A MX9202804 A MX 9202804A MX 9202804 A MX9202804 A MX 9202804A MX 9202804 A MX9202804 A MX 9202804A MX 9202804 A MX9202804 A MX 9202804A
- Authority
- MX
- Mexico
- Prior art keywords
- molecula
- pharmaceutical
- new
- therapeutic composition
- intracellular adhesion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71287991A | 1991-06-11 | 1991-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9202804A true MX9202804A (en) | 1992-12-01 |
Family
ID=24863928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9202804A MX9202804A (en) | 1991-06-11 | 1992-06-11 | PHARMACEUTICAL AND THERAPEUTIC COMPOSITION THAT INCLUDES A NEW MOLECULA OF INTRACELLULAR ADHESION. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0590051A4 (en) |
| JP (1) | JP3288042B2 (en) |
| KR (2) | KR100333120B1 (en) |
| CN (1) | CN1188528C (en) |
| BG (1) | BG61682B1 (en) |
| BR (1) | BR9206142A (en) |
| CA (1) | CA2110387A1 (en) |
| CZ (1) | CZ283478B6 (en) |
| FI (1) | FI935500A (en) |
| HU (1) | HU217176B (en) |
| IE (1) | IE921893A1 (en) |
| IL (1) | IL102176A (en) |
| MX (1) | MX9202804A (en) |
| NO (1) | NO317658B1 (en) |
| NZ (1) | NZ243114A (en) |
| RO (1) | RO115415B1 (en) |
| RU (1) | RU2130782C1 (en) |
| SK (1) | SK279937B6 (en) |
| UA (1) | UA27763C2 (en) |
| WO (1) | WO1992022323A1 (en) |
| ZA (1) | ZA924276B (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629162A (en) * | 1991-06-11 | 1997-05-13 | The Center For Blood Research | Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
| US5525487A (en) * | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
| US5811517A (en) * | 1992-01-27 | 1998-09-22 | Icos Corporation | ICAM-related protein variants |
| US5702917A (en) * | 1992-01-27 | 1997-12-30 | Icos Corporation | Polynucleotides encoding human ICAM-4 |
| WO1999018441A1 (en) * | 1992-01-27 | 1999-04-15 | Icos Corporation | Icam-4 and diagnostic uses thereof |
| US6153395A (en) * | 1992-01-27 | 2000-11-28 | Icos Corporation | ICAM-related protein |
| US5837822A (en) * | 1992-01-27 | 1998-11-17 | Icos Corporation | Humanized antibodies specific for ICAM related protein |
| US5532127A (en) * | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
| US6818743B1 (en) | 1992-01-27 | 2004-11-16 | Icos Corporation | I-CAM related protein |
| US5989843A (en) * | 1992-01-27 | 1999-11-23 | Icos Corporation | Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein |
| WO1993014776A1 (en) * | 1992-01-27 | 1993-08-05 | Icos Corporation | Icam-related protein |
| US6100383A (en) * | 1992-01-27 | 2000-08-08 | Icos Corporation | Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions |
| JPH07506007A (en) * | 1993-01-22 | 1995-07-06 | イコス コーポレイション | ICAM-related proteins |
| US6027922A (en) * | 1993-11-02 | 2000-02-22 | Innogenetics N.V. | Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| US6884590B1 (en) | 1994-02-11 | 2005-04-26 | Cedars-Sinai Medical Center | Methods of screening for ulcerative colitis and crohn's disease |
| US5681699A (en) * | 1994-02-11 | 1997-10-28 | Cedars-Sinai Medical Center | Methods of diagnosing ulcerative colitis and Crohn's disease |
| US20020081294A1 (en) | 1996-01-23 | 2002-06-27 | Genentech, Inc. | Co-administration of a thrombolytic and an anti-CD18 antibody in stroke |
| US5914112A (en) * | 1996-01-23 | 1999-06-22 | Genentech, Inc. | Anti-CD18 antibodies in stroke |
| CN1132014C (en) * | 1997-10-02 | 2003-12-24 | 艾科斯有限公司 | ICAM-4 and diagnostic uses thereof |
| ES2270868T3 (en) | 1999-08-13 | 2007-04-16 | Biogen Idec Ma Inc. | INHIBITORS OF CELL ADHESION. |
| US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
| US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
| US7691591B2 (en) * | 2002-09-20 | 2010-04-06 | Stichting Katholieke Universiteit | Methods of identifying and isolating cells expressing DC-sign |
| US7196112B2 (en) | 2004-07-16 | 2007-03-27 | Biogen Idec Ma Inc. | Cell adhesion inhibitors |
| CA2657621A1 (en) | 2006-07-14 | 2008-01-17 | Aviva Biosciences Corporation | Methods and compositions for detecting rare cells from a biological sample |
| WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
| US9580752B2 (en) | 2008-12-24 | 2017-02-28 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy |
| GB201016864D0 (en) | 2010-10-06 | 2010-11-17 | Univ Aston | Therapeutic methods |
| KR20210157418A (en) | 2013-03-27 | 2021-12-28 | 세다르스-신나이 메디칼 센터 | Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways |
| WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
| KR102464372B1 (en) | 2016-03-17 | 2022-11-04 | 세다르스-신나이 메디칼 센터 | Methods of diagnosing inflammatory bowel disease through rnaset2 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE146222T1 (en) * | 1989-03-09 | 1996-12-15 | Blood Res Center | INTERCELLULAR ADHESION MOLECULE-2 AND ITS BINDING LIGANDS |
-
1992
- 1992-06-11 WO PCT/US1992/004896 patent/WO1992022323A1/en not_active Application Discontinuation
- 1992-06-11 RU RU93058655A patent/RU2130782C1/en not_active IP Right Cessation
- 1992-06-11 NZ NZ243114A patent/NZ243114A/en unknown
- 1992-06-11 SK SK1395-93A patent/SK279937B6/en unknown
- 1992-06-11 RO RO93-01672A patent/RO115415B1/en unknown
- 1992-06-11 UA UA93003881A patent/UA27763C2/en unknown
- 1992-06-11 KR KR1020007000978A patent/KR100333120B1/en not_active IP Right Cessation
- 1992-06-11 CN CNB921051263A patent/CN1188528C/en not_active Expired - Fee Related
- 1992-06-11 IL IL10217692A patent/IL102176A/en not_active IP Right Cessation
- 1992-06-11 CA CA002110387A patent/CA2110387A1/en not_active Abandoned
- 1992-06-11 CZ CS932702A patent/CZ283478B6/en not_active IP Right Cessation
- 1992-06-11 BR BR9206142A patent/BR9206142A/en not_active Application Discontinuation
- 1992-06-11 EP EP19920914138 patent/EP0590051A4/en not_active Ceased
- 1992-06-11 MX MX9202804A patent/MX9202804A/en not_active Application Discontinuation
- 1992-06-11 JP JP50099993A patent/JP3288042B2/en not_active Expired - Fee Related
- 1992-06-11 ZA ZA924276A patent/ZA924276B/en unknown
- 1992-06-11 KR KR1019930703828A patent/KR100291844B1/en not_active IP Right Cessation
- 1992-07-01 IE IE189392A patent/IE921893A1/en not_active Application Discontinuation
-
1993
- 1993-12-08 FI FI935500A patent/FI935500A/en unknown
- 1993-12-09 NO NO934491A patent/NO317658B1/en not_active IP Right Cessation
- 1993-12-10 BG BG98287A patent/BG61682B1/en unknown
- 1993-12-10 HU HU9303529A patent/HU217176B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI935500A (en) | 1994-02-09 |
| KR100333120B1 (en) | 2002-04-18 |
| BG61682B1 (en) | 1998-03-31 |
| HU9303529D0 (en) | 1994-04-28 |
| IL102176A (en) | 2001-09-13 |
| RU2130782C1 (en) | 1999-05-27 |
| WO1992022323A1 (en) | 1992-12-23 |
| CZ283478B6 (en) | 1998-04-15 |
| CZ270293A3 (en) | 1994-08-17 |
| NZ243114A (en) | 1995-03-28 |
| BR9206142A (en) | 1994-12-27 |
| HUT66617A (en) | 1994-12-28 |
| JP3288042B2 (en) | 2002-06-04 |
| IE921893A1 (en) | 1992-12-16 |
| EP0590051A4 (en) | 1994-10-12 |
| UA27763C2 (en) | 2000-10-16 |
| NO317658B1 (en) | 2004-11-29 |
| IL102176A0 (en) | 1993-01-14 |
| SK139593A3 (en) | 1994-10-05 |
| BG98287A (en) | 1994-08-30 |
| CA2110387A1 (en) | 1992-12-23 |
| SK279937B6 (en) | 1999-06-11 |
| AU2237692A (en) | 1993-01-12 |
| JPH06509706A (en) | 1994-11-02 |
| FI935500A0 (en) | 1993-12-08 |
| NO934491L (en) | 1994-02-11 |
| AU670243B2 (en) | 1996-07-11 |
| CN1069522A (en) | 1993-03-03 |
| NO934491D0 (en) | 1993-12-09 |
| KR100291844B1 (en) | 2001-09-17 |
| HU217176B (en) | 1999-12-28 |
| CN1188528C (en) | 2005-02-09 |
| ZA924276B (en) | 1993-03-31 |
| RO115415B1 (en) | 2000-02-28 |
| EP0590051A1 (en) | 1994-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9202804A (en) | PHARMACEUTICAL AND THERAPEUTIC COMPOSITION THAT INCLUDES A NEW MOLECULA OF INTRACELLULAR ADHESION. | |
| KR950703566A (en) | Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF] | |
| DK0754061T3 (en) | New oral pharmaceutical dosage form | |
| ATA129892A (en) | PHARMACEUTICAL COMPOSITION | |
| DE69618587D1 (en) | CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS | |
| MX9202934A (en) | DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. | |
| BR1100824A (en) | Pharmaceutical composition and composition | |
| FI953479A0 (en) | 1-Arylpyrimidine derivatives and their pharmaceutical use | |
| DE69525148D1 (en) | PHARMACEUTICAL FORMULATION | |
| BR1100329A (en) | Compound and pharmaceutical formulation | |
| FI955681A (en) | Dosage form of antidepressant | |
| IS5070A (en) | A new form of the S-enantiomer of omeprazole and a pharmaceutical preparation containing it | |
| AR027162A1 (en) | COMPOUNDS OF 2-PHENYL-3-PHENOXYL-PHENYLTIO-BENZOTIOFEN, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| FI954767A (en) | Lopophilic drugs containing pharmaceutical composition | |
| KR960700239A (en) | CHROMAN DERIVATIVE AND MEDICINAL USE THEREOF | |
| DE69300913D1 (en) | Polymorph terazosin and pharmaceutical composition. | |
| BR9602915A (en) | Medicines use and pharmaceutical formulation | |
| MX9204563A (en) | NEW DERIVATIVES OF (2-ALQUIL-3-PIRIDIL) -METILPIPERAZINA AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM. | |
| DE4294862T1 (en) | Pharmaceutical composition | |
| MA22490A1 (en) | INSECTICIDE COMPOSITION AND INSECTICIDE UNIT | |
| DE69614407D1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| FR2742053B1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON MEQUITAZINE | |
| FI973229A (en) | New pharmaceutical composition | |
| ATE256465T1 (en) | ORAL MEDICINAL PREPARATION OF PIPERDINOALKANOLS IN SOLVED FORM | |
| FI964113A (en) | A pharmaceutical composition for the treatment of tardive dyskinesia and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |